Stryker/Physiotherapy settle DoJ fraud case
This article was originally published in The Gray Sheet
Stryker and its former outpatient physical therapy business Physiotherapy Associates will pay $16.6 million to settle false claims allegations, the U.S. Department of Justice announces Nov. 14. Physiotherapy will also enter a corporate integrity agreement with the Office of Inspector General. The case stems from two whistleblower suits filed by former employees. Stryker sold Physiotherapy to private equity firm Water Street Healthcare Partners in June. Part of the acquisition agreement limited Stryker's liability for any payments resulting from the DoJ investigation (1"The Gray Sheet" June 11, 2007, p. 10)
You may also be interested in...
Stryker is getting out of the physical therapy business to focus on its core orthopedic franchise
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.